However, the well‐documented heterogeneity in the Aβ–tau axis wasn't taken into account, in which female sex and younger age are consistently linked to faster tau accumulation in AD, potentially leading to earlier tauopathy onset and reduced anti‐Aβ treatment efficacy.25, 26, 27, 28, 29. This evidence concerns the gene MAPT and Alzheimer disease.